Trial Details

COMPLETED
Basic Information
Clinical ID c3967
Identifier NCT01257477
Trial Title LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions -
Participant Information
Sponsor Prometheus Laboratories
City Tuscaloosa
Country/Region United States
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2010-11
Primary Completion Date 2013-03
Completion Date 2013-03